Source link : https://newshealth.biz/health-news/novel-her2-drug-shrinks-lung-cancer-tumors-in-early-trial/
(MedPage Today) — BERLIN — An investigational oral drug currently under review with the FDA showed durable antitumor activity in patients with HER2-mutant advanced non-small cell lung cancer (NSCLC), findings from an international phase I/II… Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118084 Author : Publish date : 2025-10-22 17:31:00 Copyright for syndicated content belongs to the linked Source.
The post Novel HER2 Drug Shrinks Lung Cancer Tumors in Early Trial first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-22 17:31:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8